Supplemental Table for: The impact of dupilumab on patch testing and the prevalence of co-morbid ACD in recalcitrant atopic dermatitis: a retrospective chart review

Published: 2 October 2019| Version 1 | DOI: 10.17632/p5vwsnbxmw.1
Contributor:
Jodie Raffi

Description

Table B: Patch Test Results Before and On Dupilumab by Individual Patient

Files